Immune Design CS (IMDZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | IMDZ | PROC | LYRA | ||
Company | Immune Design CS | Procaps Group S.A. | Lyra Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 5.84 | 2.60 | 4.73 | ||
High | 5.85 | 2.60 | 4.80 | ||
Low | 5.84 | 2.60 | 4.68 | ||
Last | 5.85 | 2.89 | 4.87 | ||
Change | unch | +0.28 | +0.14 | ||
% Change | unch | +10.73% | +2.96% | ||
Volume | 103,800 | 147 | 79,533 | ||
20-Day Average Volume | 409,005 | 3,732 | 245,772 | ||
Previous Close | 5.85 | 2.61 | 4.73 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 5.84 | 2.71 | 5.19 | ||
20-Day Raw Stochastic | 100.00% | 12.73% | 3.54% | ||
20-Day Relative Strength | 88.63% | 39.96% | 38.43% | ||
Weighted Alpha | -20.50 | -45.79 | +37.58 | ||
Today's Opinion | 88% Buy | 100% Sell | 24% Buy | ||
Previous Opinion | 88% Buy | 100% Sell | 24% Buy | ||
Last Month's Opinion | 56% Buy | 56% Sell | 100% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | unch since 03/25/19 | -4.06% since 04/19/24 | -9.02% since 04/23/24 | ||
Low | 5.84 on 04/01/19 | 2.60 on 04/30/24 | 4.70 on 04/30/24 | ||
High | 5.85 on 04/01/19 | 2.99 on 04/23/24 | 5.42 on 04/24/24 | ||
1-Month | |||||
%Chg | +0.34% since 03/01/19 | -10.35% since 03/28/24 | -23.79% since 03/28/24 | ||
Low | 5.82 on 03/14/19 | 2.53 on 04/09/24 | 4.70 on 04/30/24 | ||
High | 5.85 on 04/01/19 | 3.08 on 04/03/24 | 6.36 on 04/01/24 | ||
3-Month | |||||
%Chg | +350.00% since 12/31/18 | -35.32% since 01/30/24 | +3.49% since 01/30/24 | ||
Low | 1.22 on 01/03/19 | 2.53 on 04/09/24 | 4.46 on 02/09/24 | ||
High | 5.85 on 04/01/19 | 4.15 on 01/31/24 | 6.79 on 03/27/24 | ||
6-Month | |||||
%Chg | +73.08% since 10/01/18 | -8.45% since 10/30/23 | +54.90% since 10/30/23 | ||
Low | 1.10 on 12/24/18 | 2.33 on 11/15/23 | 2.50 on 11/09/23 | ||
High | 5.85 on 04/01/19 | 4.95 on 01/11/24 | 6.79 on 03/27/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 282,935 | 294,460 | 282,584 | ||
Shares Outstanding, K | 48,365 | 112,820 | 59,743 | ||
Annual Sales | 2,200,000 | 409,920,000 | 1,560,000 | ||
Annual Net Income | -54,760,000 | 42,540,000 | -62,680,000 | ||
Last Quarter Sales | 480,000 | 118,410,000 | 150,000 | ||
Last Quarter Net Income | -13,600,000 | 8,190,000 | -15,160,000 | ||
60-Month Beta | 3.48 | 0.13 | 0.23 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | 0.08 on 12/26/23 | -0.22 on 03/21/24 | ||
Latest Earnings Date | 05/01/19 | 06/03/24 | 05/10/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 5.24 | 0.00 |